Dr. Allison Dill


Allison Dill, Ph.D. is a Research Scientist Small Molecule Design and Development at Eli Lilly and Company, Indianapolis, IN.  She received a BS in Chemistry from Indiana University in 2001, and worked for 4 years as an analytical chemist in Product Research and Development before attending graduate school.

She received her Ph.D. in Analytical Chemistry in 2011 from Purdue University, studying imaging mass spectrometry for disease state characterization.  While at Lilly, she has been responsible for the analytical control strategy of many solid oral and parenteral dosage forms and has contributed to several regulatory submissions.

She has experience developing the analytical control strategy for pediatric dosage forms.  Her recent contributions have focused on enabling the delivery of the early phase portfolio within a complex global network with responsibility for the analytical control strategy of both the active pharmaceutical ingredient and the drug product.